Obstetrics & Gynaecology · FOGSI

Fetal growth restriction

FOGSI

Source:FOGSI Focus on Fetal Growth Restriction (2018, refreshed)FIGO consensus on FGR (2021)ISUOG Practice Guidelines on Doppler in Obstetrics (2021)

Verified Apr 2026

Ask House about this guideline

Red Flags

Reversed end-diastolic flow in umbilical artery — admit; antenatal corticosteroids if 24–34 weeks; deliver per gestation and ductus venosus a-wave; involve maternal-fetal medicine^[1]
Absent end-diastolic flow with abnormal CTG or biophysical profile — deliver at any gestation ≥26 weeks if fetal viability anticipated^[1]
Severe FGR (estimated fetal weight <3rd centile) with reduced fetal movements at any gestation — same-day obstetric review including CTG and Doppler^[1]
Suspected FGR with maternal pre-eclampsia, placental abruption, or PPROM — admit; deliver per maternal and fetal status^[1]

First-line treatment

Interventions

Distinguish small-for-gestational-age from FGR^[1]
FGR = pathological failure to reach growth potential; SGA = constitutionally small with normal Dopplers and growth velocity. Delphi-consensus criteria combine size centiles with Doppler indices
Identify modifiable maternal causes^[1]
Smoking cessation; treat anaemia, thyroid disease, hypertension, infection; substance use counselling; address malnutrition
Stratified surveillance pathway^[1]
Late-onset (≥32 weeks): UA + MCA Doppler, growth every 2 weeks, CTG. Early-onset (<32 weeks): add ductus venosus, biophysical profile; tertiary maternal-fetal medicine input
Timing of delivery^[1]
EFW ≥3rd centile + normal Doppler: deliver at 37 weeks. EFW <3rd centile or abnormal UA: 36–37 weeks. AEDF: 34 weeks. REDF: 30–32 weeks. Abnormal DV or non-reassuring CTG: deliver after corticosteroid course completion if gestation permits

First-line drug therapy

Drug	Class	Adult	Paediatric	Notes
Antenatal corticosteroids — betamethasone or dexamethasone^[1]	Glucocorticoid for fetal lung maturation	Betamethasone 12 mg IM × 2 doses 24 h apart; dexamethasone 6 mg IM × 4 doses 12 h apart	—	All anticipated preterm delivery 24+0 to 34+6 weeks; consider single rescue course if delivery still anticipated >7 days after first course
Magnesium sulfate (fetal neuroprotection)^[1]	Tocolytic / neuroprotective	4 g IV over 20 min, then 1 g/h IV until delivery or 24 h	—	Anticipated delivery <32 weeks; reduces cerebral palsy risk by ~30% in survivors; monitor reflexes, respiration, urine output
Aspirin (FGR prevention in subsequent pregnancy)^[1]	Antiplatelet (low-dose)	150 mg PO at night from 12 weeks until 36 weeks (or term)	—	Prior pregnancy with FGR or pre-eclampsia, or other high-risk features; reduces recurrence; may be combined with calcium 1 g/day where dietary intake low

Antenatal corticosteroids — betamethasone or dexamethasone^[1]

Glucocorticoid for fetal lung maturation

Adult: Betamethasone 12 mg IM × 2 doses 24 h apart; dexamethasone 6 mg IM × 4 doses 12 h apart
Paediatric: —

All anticipated preterm delivery 24+0 to 34+6 weeks; consider single rescue course if delivery still anticipated >7 days after first course

Magnesium sulfate (fetal neuroprotection)^[1]

Tocolytic / neuroprotective

Adult: 4 g IV over 20 min, then 1 g/h IV until delivery or 24 h
Paediatric: —

Anticipated delivery <32 weeks; reduces cerebral palsy risk by ~30% in survivors; monitor reflexes, respiration, urine output

Aspirin (FGR prevention in subsequent pregnancy)^[1]

Antiplatelet (low-dose)

Adult: 150 mg PO at night from 12 weeks until 36 weeks (or term)
Paediatric: —

Prior pregnancy with FGR or pre-eclampsia, or other high-risk features; reduces recurrence; may be combined with calcium 1 g/day where dietary intake low

Safety-net

Reduced or absent fetal movements at any gestation — same-day maternity assessment unit; do not wait until next antenatal visit^[1]
Attend every growth scan and Doppler appointment — most FGR deterioration is silent^[1]
Stop smoking and limit caffeine; addressing modifiable factors meaningfully changes neonatal outcomes^[1]

Referral criteria

Early-onset FGR (<32 weeks)Tertiary maternal-fetal medicine and neonatal team^[1]
Abnormal umbilical artery Doppler (PI >95th, absent or reversed end-diastolic flow)Maternal-fetal medicine for delivery planning and serial DV/CTG surveillance^[1]
Suspected co-existent pre-eclampsia or placental abruptionObstetric admission^[1]
Recurrent FGR or unexplained stillbirthPre-conception MFM and consideration of thrombophilia, autoimmune workup^[1]

Clinical summary

Identification, surveillance, and timing of delivery for early- and late-onset fetal growth restriction in singleton pregnancies.

References

1.FOGSI Focus on Fetal Growth Restriction (2018, refreshed); FIGO consensus on FGR (2021); ISUOG Practice Guidelines on Doppler in Obstetrics (2021)

Drug

Class

Adult

Paediatric

Notes